» Articles » PMID: 18288598

Characterization of Asn130-to-Ala Mutant of Dengue Type 1 Virus NS1 Protein

Overview
Journal Virus Genes
Date 2008 Feb 22
PMID 18288598
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The nonstructural protein 1 (NS1) of flavivirus has two N-glycosylation sites that are thought to be important for viral replication. Effects of NS1 glycosylation site mutations on viral replication have been reported in several flaviviruses, but the results have differed. In this report, we examined the role of glycosylation site of NS1 on the replication of dengue type 1 virus (DENV-1). DENV-1 production was not detectable when full-length DENV-1 RNA, which has an N-glycosylation site Asn130-to-Ala (Asn130Ala) mutation in NS1, was transfected into mammalian and mosquito cells. However, replication and secretion of recombinant DENV-1 with the NS1 Asn130Ala mutation were recovered by exogenously expressed wild-type DENV-1 NS1. A growth kinetics experiment showed that propagation of wild-type DENV-1 was prevented by NS1 Asn130Ala mutant expression in trans. Our results suggest that Asn130 of the DENV-1 NS1 is important for viral replication in both mammalian and mosquito cells.

Citing Articles

Towards a Universal Translator: Decoding the PTMs That Regulate Orthoflavivirus Infection.

Schmidt H, Horner S Viruses. 2025; 17(2).

PMID: 40007042 PMC: 11861903. DOI: 10.3390/v17020287.


The glycosylation deficiency of flavivirus NS1 attenuates virus replication through interfering with the formation of viral replication compartments.

Huang S, Shi P, Fan X, Yang Y, Qin C, Zhao H J Biomed Sci. 2024; 31(1):60.

PMID: 38849802 PMC: 11157723. DOI: 10.1186/s12929-024-01048-z.


NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus.

Fang E, Li M, Liu X, Hu K, Liu L, Zhang Z Vaccines (Basel). 2023; 11(5).

PMID: 37243063 PMC: 10221952. DOI: 10.3390/vaccines11050959.


Glycosylation of viral proteins: Implication in virus-host interaction and virulence.

Feng T, Zhang J, Chen Z, Pan W, Chen Z, Yan Y Virulence. 2022; 13(1):670-683.

PMID: 35436420 PMC: 9037552. DOI: 10.1080/21505594.2022.2060464.


Flavivirus NS1 and Its Potential in Vaccine Development.

Carpio K, Barrett A Vaccines (Basel). 2021; 9(6).

PMID: 34207516 PMC: 8229460. DOI: 10.3390/vaccines9060622.


References
1.
Jacobs M, Robinson P, Bletchly C, Mackenzie J, Young P . Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 2000; 14(11):1603-10. DOI: 10.1096/fj.14.11.1603. View

2.
Pryor M, Wright P . Glycosylation mutants of dengue virus NS1 protein. J Gen Virol. 1994; 75 ( Pt 5):1183-7. DOI: 10.1099/0022-1317-75-5-1183. View

3.
Lin R, Chang B, Yu H, Liao C, Lin Y . Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol. 2006; 80(12):5908-18. PMC: 1472572. DOI: 10.1128/JVI.02714-05. View

4.
Lindenbach B, Rice C . trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol. 1997; 71(12):9608-17. PMC: 230269. DOI: 10.1128/JVI.71.12.9608-9617.1997. View

5.
Mackenzie J, Jones M, Young P . Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology. 1996; 220(1):232-40. DOI: 10.1006/viro.1996.0307. View